Convalescent Plasma Program

If you have fully recovered from COVID-19, please consider donating plasma to help current COVID-19 patients.

Historically, convalescent plasma has been used to prevent or treat new viral diseases, when other treatments or vaccines were not available. People who have fully recovered from COVID-19 have antibodies in their plasma that have the potential to work against the virus.

The plasma obtained from the blood of people who recovered from COVID-19 (convalescent plasma) is being evaluated as treatment for hospitalized patients with serious or immediately life-threatening COVID-19 infections, or those judged by a health care provider to be at high risk of progression to severe or life-threatening disease.

Blood specimens may also be used to better understand patients’ immune responses to COVID-19 to assist development of new therapies and vaccines.

Donating for local use

MU Health Care has joined a select group of hospitals nationwide by participating in a clinical trial to determine whether plasma found in blood from those previously infected with novel Coronavirus (COVID-19) can benefit those currently fighting the virus. Read more

Dima Dandachi, MD, an infectious disease physician, is principal investigator for the MU Health Care convalescent plasma program.

Adults who’ve recovered from COVID-19 are encouraged to participate by filling out the form below. This is an unpaid and voluntary program.

“We believe this trial could be promising, the risks to the donor are minimal, and it could save someone’s life,” Dandachi said.

Sign up to donate plasma

If you want to donate plasma to help others in need, please click the link below.

Donate Plasma